Related Content
Download content relating to this event and topic.
3rd ANZ Biologics Festival 2025
Australia and New Zealand's Preeminent Conference on Biologics
The 3rd ANZ Biologics Festival 2025 unites biopharma leaders to advance Australia & New Zealand's biologics industry through innovation partnerships and manufacturing expansion.
300
+
Attendees
120
+
Companies
40
+
Speakers
20
+
Networking Hours
10
+
Case Studies
About the Event
Excellence in Biologics Manufacturing, Cell and Gene Therapy, and RNA Therapeutics for Australia & New Zealand's Future Biologics Industry.
With a biotechnology sector benchmarked for global excellence due to world-class facilities, researchers, and regulation, the ANZ region has a promising future for biologics innovation and manufacturing. The path ahead will require a focus on further commercial translation of research, and as such, partnerships and collaborations will be critical. Expanding sovereign manufacturing in Australia & New Zealand will also play a massive role in uplifting the sector in the region.
The 3rd ANZ Biologics Festival 2025 is the region's premier conference that aims to gather the innovators, pioneers, and leaders in the biologics fraternity, including Biologics, Biosimilars, Vaccines, Cell and Gene Therapy (CGT), and RNA Therapeutics, to showcase the latest from ideation to commercialization phase and beyond. It provides the right environment to meet the entire biopharma fraternity under one roof.
Join us to bring investment to Australia & New Zealand's bio sector and explore a wealth of opportunities in biologics innovation, expanding the region's manufacturing footprint, and advancing cell and gene therapy and RNA therapeutics. The 2025 festival will feature dedicated tracks on Biologics Manufacturing, Cell and Gene Therapy, and RNA Therapeutics, offering a comprehensive view of the latest advancements and challenges in these critical areas.
Speakers
Esteemed Voices From the Industry
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Xenia Sango
Chief Executive Officer and Managing Director
Vivazome Therapeutics
Australia
Vihandha Wickramasinghe
Head, RNA Biology and Cancer Laboratory
Peter MacCallum Cancer Centre
Australia
Tim Oldham
Chief Executive Officer & Managing Director
Adalta
Australia
Thomas Preiss
Director of Shine-Dalgarno Centre for RNA Innovation, Professor of RNA Biology
The Australian National University
Australia
Tarun Saluja
Head of Clinical Development
International Vaccine Institute
South Korea
Tam C. Nguyen
Deputy Director of Research
St. Vincent’s Hospital Melbourne
Australia
Richard Berry
Vice President, Biologics & Drug Discovery
oNKo-innate
Australia
Rebecca Skinner
Director, Research and Industry Development, mRNA Victoria
Government of Victoria
Australia
Rebecca McQualter
Chief Operating Officer
Chimeric Therapeutics
Australia
Rajiv Khanna
Founder and Chief Scientific Officer, Cyteph, Director
QIMR Centre for Immunotherapy and Vaccine Development
Australia
Paul McDonald
Chief Executive Officer
IDT
Australia
Nicholas Huntington
Co-founder & CSO at oNKo-Innate, Director of Research, Cancer Immunology
Monash University
Australia
Registration
Choose a plan that fits your role, company and industry.
APAC Biopharma / Academic
SGD 2,095
FINAL CALL
END-USER PRICING IS APPLICABLE TO:
Company Profiles: Biopharma, BIG Pharmas, APAC Academic & Research Institutes in APAC (including ANZ)
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
NON-APAC Biopharma / Academic
SGD 2,595
FINAL CALL
END-USER PRICING IS APPLICABLE TO:
Company Profiles: Biopharma, BIG Pharmas, Academic & Research Institutes outisde of APAC
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
Service or Solution Provider / Big Pharma
SGD 3,595
FINAL CALL
SOLUTION PROVIDER PRICING IS APPLICABLE TO:
Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, CRO's, Asian Academic/Research Institutes.
Job Profiles: Business Development, Marketing & Sales
Want to Speak at This Event?
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Agenda at a Glance
View the agenda for
3rd ANZ Biologics Festival 2025
ANZ Biologics Festival 2025
- Current And Future State of the ANZ Biologics Market: An overview and forecast of trends, challenges, and opportunities in the biologics market in Australia and New Zealand.
- Upstream Processing – Process Optimization & Intensification: Strategies and advancements in optimizing and intensifying the initial stages of biologics production to enhance efficiency and productivity.
- Downstream Processing – Purification & Recovery for Better Product Efficiency & Yield: Techniques and innovations in purifying and recovering biologics to improve product quality and yield.
- GMP Manufacturing, Analytics & Quality Control: Best practices and technologies for ensuring Good Manufacturing Practices (GMP), precise analytics, and rigorous quality control in biologics production.
- Bioprocessing 4.0: Digitalization, AI, and Machine Learning for Manufacturing Efficiencies: Examining how digitalization, AI, and machine learning technologies are revolutionizing manufacturing processes to enhance efficiency and productivity in bioprocessing.
- Designing & Executing Clinical Trials in the ANZ Region – Lessons Learnt: Sharing insights and experiences from designing and conducting clinical trials in Australia and New Zealand, highlighting key takeaways and best practices.
- Biopharma Case Studies from ANZ Region: Presenting real-world case studies from biopharma companies in the ANZ region, showcasing successful strategies and innovations in biologics development.
- Supply-Chain Management & Temperature Controlled Logistics: Discussing strategies and solutions for effective supply-chain management and maintaining temperature control in the logistics of biologics to ensure product integrity and quality
ANZ Next-Gen Cell & Gene Therapeutics Forum
- Current & Future Prospects for Cell & Gene Therapies in ANZ: Exploring the present landscape and future opportunities for cell and gene therapies in Australia and New Zealand, including regulatory and market trends.
- Translational Strategy for Pre-Clinical and Clinical Programs: Discussing strategies to effectively transition therapies from pre-clinical research to clinical development, ensuring successful translation of scientific discoveries into clinical applications.
- Building a Global Clinical Trial for Cell & Gene Therapies: Highlighting the challenges and best practices for designing and executing international clinical trials for cell and gene therapies, with a focus on regulatory and logistical considerations.
- CGT Manufacturing Innovations for Safe, Efficient, and Scalable Therapies: Presenting cutting-edge manufacturing techniques and innovations that enhance the safety, efficiency, and scalability of cell and gene therapies.
- Case Studies: Promising CGT Therapies from ANZ: Showcasing successful case studies of innovative cell and gene therapies developed in the ANZ region, highlighting clinical outcomes and potential impact.
Next-Gen RNA Therapeutics Forum
- Growing RNA Research & Manufacturing Capability in the ANZ Region: Discussing the expansion and advancements in RNA research and manufacturing capabilities within Australia and New Zealand, focusing on infrastructure and technological developments.
- Accelerating Vaccine Manufacture with mRNA Technology: Exploring how mRNA technology is revolutionizing vaccine development and manufacturing processes, enabling faster and more efficient production.
- Optimizing Delivery Platforms for Next Gen RNA Therapeutics: Examining advanced delivery systems and technologies designed to enhance the efficacy and safety of next-generation RNA-based therapeutics.
- Case Studies: Breakthrough RNA Therapies from ANZ: Showcasing successful RNA therapies developed in the ANZ region, highlighting their innovative approaches and clinical outcomes.
Ready to attend?
Register today to get limited super access and save big.
Platinum Sponsors
Gold Sponsors
No items found.
Silver Sponsors
Bronze Sponsors
No items found.
Associate Sponsors
Exhibitors
Advertisers
Want to Sponsor This Event?
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Frequently Asked Questions
How can I stay updated on event details and announcements?
To stay informed about event updates, including date, venue, and agenda, please subscribe to our newsletter on our event website. You can also follow our official social media channels for real-time updates and announcements.
What can I expect to learn and explore during the event?
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
What safety measures will be in place to ensure the safety of attendees?
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Is there a cancellation or refund policy if I can't attend after registering?
Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.
Can I submit a presentation to be a speaker at this event?
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
What type of professionals benefit most from attending?
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
What advantages does this conference offer participants?
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Are there networking opportunities or special events planned?
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Are there sponsorship opportunities for this event?
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
How can I register for the event?
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Be a Part of This Event!
Don't miss out on unique networking, speaking and sponsorship opportunities.